Endorphins, lithium, and naloxone: their relationship to pathological and drug-induced manic-euphoric states.
D000328:Adult; D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D001714:Bipolar Disorder / Q000139:chemically induced*; D003042:Cocaine / Q000037:antagonists & inhibitors; D004298:Dopamine / Q000378:metabolism; D004723:Endorphins / Q000494:pharmacology*; D005059:Euphoria / Q000187:drug effects*; D006556:Heroin Dependence / Q000534:rehabilitation; D006801:Humans; D008094:Lithium / Q000494:pharmacology*; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D009270:Naloxone / Q000494:pharmacology*; D011388:Prolactin / Q000097:blood; D011957:Receptors, Opioid / Q000187:drug effects
D004723:Endorphins; D011957:Receptors, Opioid; D009270:Naloxone; D011388:Prolactin; D008094:Lithium; D000661:Amphetamine; D003042:Cocaine; D008691:Methadone; D004298:Dopamine